BIOTON S.A. (WSE:BIO)
4.200
+0.020 (0.48%)
May 30, 2025, 5:03 PM CET
BIOTON Income Statement
Financials in millions PLN. Fiscal year is January - December.
Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Revenue | 207.76 | 181.64 | 233.16 | 163.03 | 221.79 |
Revenue Growth (YoY) | 14.38% | -22.10% | 43.01% | -26.49% | 9.78% |
Cost of Revenue | 142.92 | 108.78 | 137.41 | 86.72 | 121.48 |
Gross Profit | 64.84 | 72.85 | 95.75 | 76.32 | 100.31 |
Selling, General & Admin | 67.2 | 71.46 | 65.34 | 59.69 | 73.74 |
Research & Development | 4.04 | 5.51 | 5.34 | 4.67 | 4 |
Other Operating Expenses | -0.78 | -0.39 | 0.92 | -1.49 | -32.73 |
Operating Expenses | 70.47 | 76.58 | 71.6 | 62.87 | 45 |
Operating Income | -5.63 | -3.72 | 24.15 | 13.45 | 55.31 |
Interest Expense | -7.53 | -8.24 | -7.86 | -4.54 | -5.07 |
Interest & Investment Income | 0.2 | - | - | - | 0 |
Currency Exchange Gain (Loss) | 1.58 | 0.37 | -7.86 | -1.37 | -2.69 |
Other Non Operating Income (Expenses) | -0.42 | -0.18 | -0.59 | -0.1 | -0.35 |
EBT Excluding Unusual Items | -11.8 | -11.78 | 7.85 | 7.44 | 47.2 |
Merger & Restructuring Charges | -0.09 | -0.04 | 0.01 | -0.17 | -1.01 |
Gain (Loss) on Sale of Investments | - | - | - | - | 1.14 |
Gain (Loss) on Sale of Assets | 0 | 3.11 | -0.6 | 2.66 | -1.34 |
Asset Writedown | -0.08 | -0.01 | -2.72 | -1.6 | -5.27 |
Legal Settlements | 0.01 | - | 0.3 | - | - |
Other Unusual Items | 0.07 | 15.95 | 0.12 | - | 0.88 |
Pretax Income | -11.88 | 7.23 | 4.95 | 8.33 | 41.61 |
Income Tax Expense | 3.78 | 4.96 | 3.53 | 5.45 | 7.69 |
Earnings From Continuing Operations | -15.66 | 2.28 | 1.42 | 2.88 | 33.92 |
Net Income to Company | -15.66 | 2.28 | 1.42 | 2.88 | 33.92 |
Net Income | -15.66 | 2.28 | 1.42 | 2.88 | 33.92 |
Net Income to Common | -15.66 | 2.28 | 1.42 | 2.88 | 33.92 |
Net Income Growth | - | 60.10% | -50.69% | -91.50% | - |
Shares Outstanding (Basic) | 86 | 86 | 86 | 86 | 86 |
Shares Outstanding (Diluted) | 86 | 86 | 86 | 86 | 86 |
EPS (Basic) | -0.18 | 0.03 | 0.02 | 0.03 | 0.40 |
EPS (Diluted) | -0.18 | 0.03 | 0.02 | 0.03 | 0.40 |
EPS Growth | - | 60.10% | -44.84% | -92.41% | - |
Free Cash Flow | 25.14 | -4.54 | 26.5 | -7.37 | 37.27 |
Free Cash Flow Per Share | 0.29 | -0.05 | 0.31 | -0.09 | 0.43 |
Gross Margin | 31.21% | 40.11% | 41.07% | 46.81% | 45.23% |
Operating Margin | -2.71% | -2.05% | 10.36% | 8.25% | 24.94% |
Profit Margin | -7.54% | 1.25% | 0.61% | 1.77% | 15.29% |
Free Cash Flow Margin | 12.10% | -2.50% | 11.37% | -4.52% | 16.80% |
EBITDA | 18.8 | 31.26 | 58.56 | 45.09 | 87.04 |
EBITDA Margin | 9.05% | 17.21% | 25.11% | 27.66% | 39.25% |
D&A For EBITDA | 24.42 | 34.98 | 34.4 | 31.64 | 31.73 |
EBIT | -5.63 | -3.72 | 24.15 | 13.45 | 55.31 |
EBIT Margin | -2.71% | -2.05% | 10.36% | 8.25% | 24.94% |
Effective Tax Rate | - | 68.55% | 71.30% | 65.41% | 18.48% |
Advertising Expenses | 7.26 | 10.14 | 8.28 | 7.26 | 8.12 |
Updated Feb 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.